SQZ Biotechnologies ROA 2020-2022 | SQZ
Current and historical return on assets (ROA) values for SQZ Biotechnologies (SQZ) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
SQZ Biotechnologies ROA - Return on Assets Historical Data |
Date |
TTM Net Income |
Total Assets |
Return on Assets |
2022-12-31 |
$-0.08B |
$0.10B |
-50.31% |
2022-09-30 |
$-0.08B |
$0.16B |
-40.94% |
2022-06-30 |
$-0.08B |
$0.18B |
-36.19% |
2022-03-31 |
$-0.07B |
$0.20B |
-32.53% |
2021-12-31 |
$-0.07B |
$0.23B |
-27.98% |
2021-09-30 |
$-0.07B |
$0.24B |
-30.30% |
2021-06-30 |
$-0.06B |
$0.24B |
-28.13% |
2021-03-31 |
$-0.06B |
$0.26B |
-32.79% |
2020-12-31 |
$-0.05B |
$0.23B |
-50.00% |
2020-06-30 |
$-0.03B |
$0.00B |
inf% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.024B |
$0.021B |
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|